PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255978
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1255978
Inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from inferior part of the body to the heart. An inferior vena cava filter is implanted in the inferior vena cava to capture embolism, blood clot, preventing them from reaching the lungs. Implantation of these devices is either permanent or temporary depending upon the need of therapy. The prominent factors that fuel the growth of the global inferior vena cava (IVC) filters market include a rise in preference for minimally invasive surgeries with improved medical imaging across various medical settings. However, the global market growth is restricted by the high cost of procedures associated with IVC filters. Furthermore, emergence of digital catheterization laboratories is anticipated to offer lucrative opportunities for the expansion of the market. According to the American Thoracic Society, in 2016, the incidence of diagnosed pulmonary embolism range from 71 to 117 per 100,000 person-year in the United States. High diagnosis rate of pulmonary embolism contribute to the growth of the global market.
The global IVC filters market is segmented based on product types, end-users, and geography. Based on product type, the global IVC filters market is classified as permanent inferior vena cava filters and retrievable inferior vena cava filters. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers (ASCs), and others. Among end-user segments, hospitals have dominated the global market in 2017 and are anticipated to retain their prominence during the forecast period due to the high usage of IVC filters for cardiac surgeries.
Geographically, North America dominated the global market owing to the high prevalence and awareness regarding cardiovascular diseases and the availability of evolved healthcare infrastructure. Manufacturers are focusing on emerging markets including the Asia Pacific and Latin America for further expansion due to the presence of potential opportunities.
Key Players Identified in the Inferior Vena Cava (IVC) Filters Market include:
Cardinal Health, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, C. R. Bard, ALN, VENITI, Inc., Argon Medical Devices, Inc., Braile Biomdica, and Koninklijke Philips N.V. (Philips Volcano).
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Inferior Vena Cava (IVC) Filters market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Inferior Vena Cava (IVC) Filters market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product
Retrievable IVC Filter
Permanent IVC Filter
Application
Treatment Venous Thromboembolism (VTE)
Prevent Pulmonary Embolism (PE)
Others
End User
Hospitals
Ambulatory Surgical Centers (ASCs)
Others
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Inferior Vena Cava (IVC) Filters market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Inferior Vena Cava (IVC) Filters market?
Which is the largest regional market for Inferior Vena Cava (IVC) Filters market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Inferior Vena Cava (IVC) Filters market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Inferior Vena Cava (IVC) Filters market worldwide?